In February, Ryan Woods, MD, will provide regenerative medicine services to patients at Orthopedics & Sports Medicine BayCare Clinic in Manitowoc, Wis., according to the Herald Times Reporter. By Alan Condon - 1/17/20

NanoFUSE Biologics appointed Answorth Allen, MD, Jan. 16 to its scientific advisory board, reports Benzinga. By Alan Condon - 1/16/20

The potential of spine-targeted biologics is immense and quickly developing. Here are four recent stories on notable developments or recognitions: By Eric Oliver - 1/16/20

Stem Cells Translational Medicine recently awarded Mohamad Khazaei, PhD, its Young Investigator Award for his research on cell-based treatments for spinal cord injuries, reports News Medical Life Sciences. By Alan Condon - 1/10/20

Orthobiologic developer Bone Biologics said its rhNELL-1 product promoted bone formation in advanced spine models. By Eric Oliver - 1/9/20

Developmental biologist Olivier Pourquié, PhD, identified a cellular segmentation clock-like mechanism in humans that controls spine development, The Harvard Gazette reports. By Eric Oliver - 1/9/20

Ortho-biologics company Royal Biologics launched Magnus, a DMSO-free viable cellular bone allograft, the first of its kind to be DMSO-free. By Eric Oliver - 1/8/20

NanoFUSE Biologics named Darren Lebl, MD, to its scientific advisory board. By Laura Dyrda - 12/31/19

Bioventus is partnering with Blue Cross Blue Shield of Michigan to provide its knee osteoarthritis treatments to Medicare Advantage and Commercial patients, beginning Jan. 1, 2020. By Alan Condon - 12/18/19

Here are nine key developments in stem cell research for spine this year: By Alan Condon - 12/16/19

Grand Rapids, Mich.-based Helen DeVos Children's Hospital provided a $2.1 million gene therapy drug for spinal muscular atrophy to a one-year-old girl in November, reports Fox 47 News. By Alan Condon - 12/16/19

Dr. Conor Buckley, director of biomedical engineering at Trinity College Dublin in Ireland, received a European Research Grant to study spinal regeneration on Dec. 10, reports The Irish Times. By Alan Condon - 12/11/19

Anika launched Tactoset, its new surgical therapy for bone repair procedures at the Orthopaedic Summit 2019: Evolving Techniques, which is taking place in Las Vegas, Dec. 11-14. By Alan Condon - 12/11/19

While biologic-based treatments have loads of promise when it comes to orthopedics, illegal actors are tarnishing the space and promoting false narratives that hurt scientific advances.  By Eric Oliver - 12/10/19

ElevateBio appointed Melissa Carpenter, PhD, as chief scientific officer of regenerative medicine Dec. 9. By Alan Condon - 12/9/19

The FDA cleared EmCyte's Progenikine Concentrating System for adipose lipoplasty for procedures in several specialties including neurosurgery and orthopedics. By Alan Condon - 12/3/19

Rochester, Minn.-based Mayo Clinic is in the midst of analyzing a stem cell therapy for spine injuries, the Minneapolis StarTribune reports. By Eric Oliver - 12/2/19

The Arthroscopy Association of North America, American Orthopaedic Society for Sports Medicine, International Cartilage Repair Society and ON Foundation have partnered to form The Biologics Alliance. By Eric Oliver - 11/25/19

The U.S. Department of Defense's Peer Reviewed Orthopaedic Research Program recently provided the University of Arkansas at Little Rock with a $750,000 grant to study the NuCress scaffold's ability to combat infection while regenerating bone, reports Newswise. By Alan Condon - 11/25/19

SpineOvations initiated a pilot clinical study of DiscSeal in patients suffering from lumbar spine pain after recently receiving Australian regulatory approval. By Alan Condon - 11/21/19